R-CHOEP-14 regimen

Jump to navigation Jump to search

WikiDoc Resources for R-CHOEP-14 regimen

Articles

Most recent articles on R-CHOEP-14 regimen

Most cited articles on R-CHOEP-14 regimen

Review articles on R-CHOEP-14 regimen

Articles on R-CHOEP-14 regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on R-CHOEP-14 regimen

Images of R-CHOEP-14 regimen

Photos of R-CHOEP-14 regimen

Podcasts & MP3s on R-CHOEP-14 regimen

Videos on R-CHOEP-14 regimen

Evidence Based Medicine

Cochrane Collaboration on R-CHOEP-14 regimen

Bandolier on R-CHOEP-14 regimen

TRIP on R-CHOEP-14 regimen

Clinical Trials

Ongoing Trials on R-CHOEP-14 regimen at Clinical Trials.gov

Trial results on R-CHOEP-14 regimen

Clinical Trials on R-CHOEP-14 regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on R-CHOEP-14 regimen

NICE Guidance on R-CHOEP-14 regimen

NHS PRODIGY Guidance

FDA on R-CHOEP-14 regimen

CDC on R-CHOEP-14 regimen

Books

Books on R-CHOEP-14 regimen

News

R-CHOEP-14 regimen in the news

Be alerted to news on R-CHOEP-14 regimen

News trends on R-CHOEP-14 regimen

Commentary

Blogs on R-CHOEP-14 regimen

Definitions

Definitions of R-CHOEP-14 regimen

Patient Resources / Community

Patient resources on R-CHOEP-14 regimen

Discussion groups on R-CHOEP-14 regimen

Patient Handouts on R-CHOEP-14 regimen

Directions to Hospitals Treating R-CHOEP-14 regimen

Risk calculators and risk factors for R-CHOEP-14 regimen

Healthcare Provider Resources

Symptoms of R-CHOEP-14 regimen

Causes & Risk Factors for R-CHOEP-14 regimen

Diagnostic studies for R-CHOEP-14 regimen

Treatment of R-CHOEP-14 regimen

Continuing Medical Education (CME)

CME Programs on R-CHOEP-14 regimen

International

R-CHOEP-14 regimen en Espanol

R-CHOEP-14 regimen en Francais

Business

R-CHOEP-14 regimen in the Marketplace

Patents on R-CHOEP-14 regimen

Experimental / Informatics

List of terms related to R-CHOEP-14 regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Etoposide-Prednisone regimen

Overview

R-CHOEP-14 regimen refers to a two-week regimen consisting of rituximab,cyclophosphamide, doxorubicin (hydroxydaunorubicin, vincristine (Oncovin), etoposide, and prednisone used to treat diffuse large B-cell lymphoma.[1]

Regimen

RRituximab

CCyclophosphamide

HDoxorubicin (Hydroxydaunomycin)

OVincristine (Oncovin)

EEtoposide

PPrednisone

Indications

References

  1. 1.0 1.1 Gang AO, Strøm C, Pedersen M, d'Amore F, Pedersen LM, Bukh A; et al. (2012). "R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group". Ann Oncol. 23 (1): 147–53. doi:10.1093/annonc/mdr058. PMID 21460380.